Abstract:Objective To explore the effects of emodin on metastatic ability and sensitivity to cisplatin of cervical cancer cells in vitro and to provide novel insights for the treatment of cervical cancer.Methods HeLa cells were divided into control group, cisplatin group, emodin group and combination group. The cell invasion, proliferation, apoptosis and migration were detected by transwell assay, MTT assay, flow cytometry, and scratch assay. The effect of emodin on the PI3K/Akt signaling pathway was analyzed by Western blotting.Results The optical density (OD) at 24 h, 36 h and 72 h in the control group, cisplatin group, emodin group and combination group was compared via the repeated measures ANOVA, and the results revealed that the OD was different among the time points (F =396.000, P =0.000) and the groups (F = 158.500, P = 0.000), and that the OD in the combination group was lower than that in the control group, cisplatin group and emodin group (P < 0.05). Besides, The change trend of OD was also different among the groups (F = 39.100, P = 0.000). Compared with the control group, the number of colonies of cervical cancer cells, the number of invasive cells, and the rate of migration in the emodin group and the cisplatin group were lower (P < 0.05). The number of colonies of cervical cancer cells, the number of invasive cells, and the rate of migration in the combination group were lower than those in the other groups (P < 0.05). In comparison with the control group, the apoptosis rate of cervical cancer cells was higher in the emodin group and cisplatin group (P < 0.05), while the apoptosis rate of cervical cancer cells in the combination group was higher than that in the other three groups (P < 0.05). The phosphorylation levels of the PI3K and Akt proteins were lower in the emodin group and cisplatin group relative to those in the control group (P < 0.05), whereas they were lower in the combination group than in the rest groups (P < 0.05).Conclusions Emodin might regulate the growth, invasion and migration of cervical cancer cells. In addition, emodin could induce apoptosis of cervical cancer cells and increase the sensitivity of cervical cancer cells to cisplatin, which is potentially attributed to the modulation of the PI3K/Akt signaling pathway.